Seeking Alpha

GSK
GlaxoSmithKline

5/27/2012, 4:31 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
GSK Market Currents more »
  • Friday 3:06 PM Human Genome (HGSI +0.6%) should still see a higher bid , says Baird, noting they "remain confident" that a higher bid will emerge despite Glaxo's (GSK +0.3%) indication it will suspend the tender offer while the company's poison pill is in effect. The firm met with management and said their calculations point to a bid closer to $20.
    Comment!
    [Healthcare]
  • Thursday 12:07 PM Human Genome (HGSI -2.4%) slips on a BMO downgrade to Market Perform. THe firm believes the risk of GlaxoSmithKline (GSK) dropping its offer has increased and the likelihood of an significant price increase or a contingent value right for darapladib has been reduced. The firm lowers its price target to $13 from $17.
    Comment!
    [Healthcare, On the Move]
  • Wednesday 8:55 AM GSK (GSK) ammends the conditions of its $2.6B tender offer for Human Genome (HGSI), requiring that the latter redeem or invalidate its poison pill.
    Comment!
    [Healthcare, M&A]
GSK in Focus more »
GSK Instablog posts more »
  • Warren Buffett - Berkshire Hathaway Q1/2012 Fund Portfolio
    Mon, May 21 • Dividend Sheet • Comment!
  • Aerocrine AB Treating Inflammatory Airway Diseases
    Thu, Apr 12 • V.I.P. • Comment!
  • The Perfect Rx For Your Portfolio
    Tue, Apr 3 • TomAspray • Comment!
  • 13 Large Cap Dividend Stocks At New 52-Week-Highs
    Wed, Mar 28 • Dividend Sheet • Comment!
  • 8 High Yield Stocks Before Crossing New 52-Week Highs
    Tue, Mar 13 • Dividend Sheet • Comment!
Write a post on GSK
GSK StockTalks
GSK vs. ETF Alternatives
Company Description
Currently, there's no company description for GSK.